Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries
Open accessAbstract
Zidovudine (AZT) is an antiretroviral drug that is a substrate of active efflux transporters (AETs) that extrude the drug from the central nervous system (CNS) and macrophages, which are considered to be sanctuaries of HIV. The conjugation of AZT to ursodeoxycholic acid is known to produce a prodrug (UDCA-AZT) that is able to elude the AET systems, indicating the potential ability of this prodrug to act as a carrier of AZT in the CNS and in macrophages. Here, we demonstrate that UDCA-AZT is able to permeate and remain in murine macrophages with an efficiency twenty times higher than that of AZT. Moreover, we propose the nasal administration of this prodrug in order to induce its uptake into the CNS. Chitosan chloride-based microparticles (CP) were prepared by spray-drying and were characterized with respect to size, morphology, density, water uptake and the dissolution profile of UDCA-AZT. The CP sample was then nasally administered to rats. All in vitro and in vivo measurements were also performed for a CP parent physical mixture. The CP sample was able to increase the dissolution rate of UDCA-AZT and to reduce water uptake with respect to its parent physical mixture, inducing better uptake of UDCA-AZT into the cerebrospinal fluid of rats, where the prodrug can act as an AZT carrier in macrophages.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Because of the direct connection provided by the olfactory and trigeminal nerves between the olfactory epithelium and the brain, drug targeting can be achieved by administering formulations onto the nasal mucosa.
“Thanks to the direct connection provided by the olfactory and trigeminal nerves present between the olfactory epithelium and the brain, drug targeting can be achieved with the administration of formulations onto nasal mucosa [10,11,12].”
From Nanoemulsions for “Nose-to-Brain” Drug Delivery (2019) · cites this paper as [12]
Cites
Intranasal delivery to the central nervous system: Mechanisms and experimental considerations
Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239 · see citing works
Chitosan microspheres as a potential carrier for drugs
Sinha, V. R., Singla, A. K., Wadhawan, S., Kaushik, R., Kumria, R., Bansal, K., & Dhawan, S. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.12.026 · Cited by 1,129 · see citing works
Chitosan-based drug delivery systems
Bernkop‐Schnürch, A., & Dünnhaupt, S. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.04.007 · Cited by 994 · see citing works
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907 · see citing works
HIV-1 Antiretroviral Drug TherapyPreprint
Arts, E. J., & Hazuda, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007161 · Cited by 856 · see citing works
Nanoparticles for direct nose-to-brain delivery of drugs
Mistry, A., Stolnik, S., & Illum, L. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.019 · Cited by 734 · see citing works
Sosnik, A., & Seremeta, K. P. (2015) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2015.05.003 · Cited by 679 · see citing works
Chitosan as a Novel Nasal Delivery System for Peptide Drugs
Illum, L., Farraj, N. F., & Davis, S. S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018901302450 · Cited by 630 · see citing works
Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.
De Clercq, E. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.10.010 · Cited by 627 · see citing works
Effect of chitosan on epithelial permeability and structure
Dodane, V. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00030-7 · Cited by 579 · see citing works
Early viral brain invasion in iatrogenic human immunodeficiency virus infection
Davis, L. E., Hjelle, B. L., Miller, V., Palmer, D. L., Llewellyn, A. L., Merlin, T. L., Young, S. A., Mills, R., Wachsman, W., & Wiley, C. A. (1992) · Neurology · doi:10.1212/wnl.42.9.1736 · Cited by 557 · see citing works
Delivery of Neurotrophic Factors to the Central Nervous System: Pharmacokinetic Considerations
Thorne, R. G., & Frey, W. H. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140120-00003 · Cited by 487 · see citing works
Principles of pharmacology : the pathophysiologic basis of drug therapy
Golan, D. E., & Tashjian, A. H. (2012) · Cited by 473 · see citing works
Chitosan in nasal delivery systems for therapeutic drugs
Casettari, L., & Illum, L. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.003 · Cited by 448 · see citing works
Is nose-to-brain transport of drugs in man a reality?
Illum, L. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022539 · Cited by 439 · see citing works
Chaudhary, P., Mechetner, E., & Roninson, I. B. (1992) · Blood · doi:10.1182/blood.v80.11.2735.bloodjournal80112735 · Cited by 345 · see citing works
Chaudhary, P., Mechetner, E., & Roninson, I. B. (1992) · Blood · doi:10.1182/blood.v80.11.2735.2735 · Cited by 281 · see citing works
Neuropathology of Early HIV‐1 Infection
Gray, F., Scaravilli, F., Everall, I., Chrétien, F. C., An, S., Boche, D., Adle‐Biassette, H., Wingertsmann, L., Durigon, M., Hurtrel, B., et al. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00775.x · Cited by 262 · see citing works
Intranasal Drug Delivery for Brain Targeting
Vyas, T. K., Shahiwala, A., Marathe, S., & Misra, A. R. (2005) · Current Drug Delivery · doi:10.2174/1567201053586047 · Cited by 257 · see citing works
Nasal delivery systems and their effect on deposition and absorption
Kublik, H., & Vidgren, M. T. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00067-7 · Cited by 249 · see citing works
Johnson, N. J., Hanson, L. R., & Frey, W. H. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100029t · Cited by 194 · see citing works
Ghersi‐Egea, J., Finnegan, W., Chen, J.-L., & Fenstermacher, J. D. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00281-3 · Cited by 151 · see citing works
Rassu, G., Soddu, E., Cossu, M., Brundu, A., Cerri, G., Marchetti, N., Ferraro, L., Regan, R. F., Giunchedi, P., Gavini, E., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.025 · Cited by 143 · see citing works
Self-citationCunningham, P., Smith, D. G., Satchell, C. S., et al. (2000) · AIDS · doi:10.1097/00002030-200009080-00010 · Cited by 143 · see citing works
Finger, T. E., Jeor, V. L. S., Kinnamon, J. C., & Silver, W. L. (1990) · The Journal of Comparative Neurology · doi:10.1002/cne.902940212 · Cited by 127 · see citing works
Wang, H., Wu, L., & Reinhard, B. M. (2012) · ACS Nano · doi:10.1021/nn302186n · Cited by 120 · see citing works
Horvát, S., Fehér, A., Wolburg, H., Sipos, P., Veszelka, S., Tóth, A. E., Kis, L., Kurunczi, A., Balogh, G. E., Kürti, L., et al. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.10.009 · Cited by 117 · see citing works
Chamberlain, L. M., Godek, M. L., Gonzalez‐Juarrero, M., & Grainger, D. W. (2009) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31930 · Cited by 112 · see citing works
Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity
van den Berg, M. P., Romeijn, S. G., Verhoef, J. C., & Merkus, F. W. H. M. (2002) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(02)00033-x · Cited by 104 · see citing works
Multidrug-resistance phenotype of a subpopulation of T-lymphocytes without drug selection
Neyfakh, A. A., Serpinskaya, A. S., Chervonsky, A. V., et al. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90318-2 · Cited by 99 · see citing works
Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review
Rassu, G., Soddu, E., Cossu, M., Gavini, E., Giunchedi, P., & Dalpiaz, A. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2015.05.002 · Cited by 87 · see citing works
Self-citationDalpiaz, A., Paganetto, G., Pavan, B., Fogagnolo, M., Medici, A., Beggiato, S., & Perrone, D. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200565g · Cited by 78 · see citing works
Self-citationBrain uptake of an anti-ischemic agent by nasal administration of microparticles
Dalpiaz, A., Gavini, E., Colombo, G., Russo, P., Bortolotti, F., Ferraro, L., Tanganelli, S., Scatturin, A., Menegatti, E., & Giunchedi, P. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21335 · Cited by 75 · see citing works
Self-citationReverse Transcription of Retroviruses and LTR Retrotransposons
Hughes, S. H. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0027-2014 · Cited by 73 · see citing works
Tang, M. W., Kanki, P., & Shafer, R. W. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir1034 · Cited by 72 · see citing works
Zidovudine Transport in the Rabbit Brain during Intravenous and Intracerebroventricular Infusion
Wang, Y., & Sawchuk, R. J. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840717 · Cited by 67 · see citing works
Maestrelli, F., Zerrouk, N., Chemtob, C., & Mura, P. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.11.024 · Cited by 64 · see citing works
Nasal Absorption of Zidovudine and Its Transport to Cerebrospinal Fluid in Rats.
Seki, T., Sato, N., Hasegawa, T., et al. (1994) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.17.1135 · Cited by 63 · see citing works
Strazielle, N., Belin, M., & Ghersi‐Egea, J. (2003) · AIDS · doi:10.1097/00002030-200307040-00008 · Cited by 62 · see citing works
Namanja, H. A., Emmert, D., Davis, D. A., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja206867t · Cited by 61 · see citing works
Fine, J. M., Renner, D. B., Forsberg, A. C., Cameron, R. A., Galick, B. T., Le, C., Conway, P. M., STROEBEL, B. M., Frey, W. H., & Hanson, L. R. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.11.013 · Cited by 61 · see citing works
Brain Uptake of a Zidovudine Prodrug after Nasal Administration of Solid Lipid Microparticles
Dalpiaz, A., Ferraro, L., Perrone, D., Leo, E., Iannuccelli, V., Pavan, B., Paganetto, G., Beggiato, S., & Scalia, S. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400735c · Cited by 59 · see citing works
Self-citationKolson, D. L., & González‐Scarano, F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10553 · Cited by 57 · see citing works
Kelmer, E., Kazmier, P., Rahaman, M. N., Bal, B. S., Tessman, R. K., & Estes, D. M. (2003) · Journal of Orthopaedic Research® · doi:10.1016/j.orthres.2003.10.022 · Cited by 56 · see citing works
Gavini, E., Rassu, G., Ferraro, L., Generosi, A., Rau, J. V., Brunetti, A., Giunchedi, P., & Dalpiaz, A. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22382 · Cited by 54 · see citing works
Self-citationCunningham, A. L., Naif, H. M., Saksena, N. K., et al. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.1.117 · Cited by 54 · see citing works
Nasal Absorption of Dihydroergotamine from Liquid and Powder Formulations in Rabbits
Marttin, E., Romeijn, S. G., Verhoef, J. C., & Merkus, F. W. H. M. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960500j · Cited by 51 · see citing works
Kaufmann, G. R., & Cooper, D. A. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00131-4 · Cited by 49 · see citing works
Shelley, C. S., Teodoridis, J. M., Park, H., Farokhzad, O. C., Böttinger, E. P., & Arnaout, M. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.3887 · Cited by 48 · see citing works
Rassu, G., Gavini, E., Jonassen, H., Zambito, Y., Fogli, S., Breschi, M. C., & Giunchedi, P. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21751 · Cited by 46 · see citing works
Self-citationMagnani, M., Casabianca, A., Fraternale, A., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4403 · Cited by 46 · see citing works
Cho, W., Kim, M., Jung, M.-S., et al. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.11.051 · Cited by 44 · see citing works
Rassu, G., Nieddu, M., Bosi, P., Trevisi, P., Colombo, M., Priori, D., Manconi, M., Giunchedi, P., Gavini, E., & Boatto, G. (2014) · Phytomedicine · doi:10.1016/j.phymed.2014.07.017 · Cited by 41 · see citing works
Self-citationPavan, B., & Dalpiaz, A. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798194486 · Cited by 40 · see citing works
Self-citationFine, J. M., Forsberg, A. C., Renner, D. B., Faltesek, K. A., Mohan, K., Wong, J. C., Arneson, L. C., Crow, J. M., Frey, W. H., & Hanson, L. R. (2014) · Brain Research · doi:10.1016/j.brainres.2014.05.048 · Cited by 39 · see citing works
Caffeine microparticles for nasal administration obtained by spray drying
Sacchetti, C., Artusi, M., Santi, P., et al. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00177-1 · Cited by 38 · see citing works
Giacalone, G., Bochot, A., Fattal, E., et al. (2013) · Biomacromolecules · doi:10.1021/bm301832v · Cited by 38 · see citing works
Rausch, D. M., & Stover, E. S. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00154-8 · Cited by 36 · see citing works
Tabletted polylactide microspheres prepared by a w/o emulsion-spray drying method
Giunchedi, E. G. P. (2000) · Journal of Microencapsulation · doi:10.1080/02652040050161701 · Cited by 25 · see citing works
Mucoadhesive Drug Delivery Systems for Nose-to-Brain Targeting of Dopamine
Gavini, E., Rassu, G., Ciarnelli, V., et al. (2012) · Journal of Nanoneuroscience · doi:10.1166/jns.2012.1015 · Cited by 7 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Nanoemulsions for “Nose-to-Brain” Drug Delivery
Bonferoni, M. C., Rossi, S., Sandri, G., Ferrari, F., Gavini, E., Rassu, G., & Giunchedi, P. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020084 · Cited by 269 · see citing works
Self-citationNose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer’s therapy
Rassu, G., Soddu, E., Posadino, A. M., Pintus, G., Sarmento, B., Giunchedi, P., & Gavini, E. (2017) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2017.01.031 · Cited by 239 · see citing works
Self-citationRassu, G., Porcu, E. P., Fancello, S., Obinu, A., Senes, N., Galleri, G., Migheli, R., Gavini, E., & Giunchedi, P. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics11010008 · Cited by 107 · see citing works
Self-citation
- Authors
- Dalpiaz, A., Fogagnolo, M., Ferraro, L., Capuzzo, A., Pavan, B., Rassu, G., Salis, A., Giunchedi, P., & Gavini, E.
- Affiliations
- University of Ferrara (IT)
- University of Sassari (IT)
- Corresponding author
- Rassu, Giovanna
- ORCID
- Venue
- Antiviral Research
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 123
- Pages
- 146-157
- ISSN
- 0166-3542 (ISSN-L)
- OpenAlex
- W1804367766
- Cited by
- 63
- References
- 60
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 5 · 2023: 8 · 2022: 5 · 2021: 5 · 2020: 5 · 2019: 8 · 2018: 9 · 2017: 8 · 2016: 3
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Antiviral Research (publishedVersion)
- PubMed (publishedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion, cc-by-nc-nd)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, cc-by-nc-nd)
- Funders
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- zidovudine, prodrugs, chitosan microspheres, intranasal drug delivery, macrophages, cerebrospinal fluid, spray drying, dissolution rate, water absorption, antiretroviral drug delivery
- MeSH terms
- Administration, Intranasal, Animals, Antiviral Agents, Brain Chemistry, Capsules, Drug Carriers, Male, Prodrugs, Ursodeoxycholic Acid, Zidovudine, Rats, Wistar, Chitosan
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review